O Shaughnessy Asset Management LLC boosted its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 54.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 328,178 shares of the pharmacy operator’s stock after buying an additional 115,452 shares during the period. O Shaughnessy Asset Management LLC’s holdings in Walgreens Boots Alliance were worth $23,839,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently made changes to their positions in WBA. Asset Dedication LLC grew its stake in shares of Walgreens Boots Alliance by 204.6% during the 3rd quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock worth $115,000 after acquiring an additional 1,060 shares in the last quarter. BlueMountain Capital Management LLC bought a new position in shares of Walgreens Boots Alliance during the 2nd quarter worth approximately $103,000. CSat Investment Advisory L.P. bought a new position in shares of Walgreens Boots Alliance during the 2nd quarter worth approximately $104,000. Squar Milner Financial Services LLC bought a new position in shares of Walgreens Boots Alliance during the 2nd quarter worth approximately $106,000. Finally, Kaizen Advisory LLC grew its stake in shares of Walgreens Boots Alliance by 128.6% during the 2nd quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after acquiring an additional 1,083 shares in the last quarter. Hedge funds and other institutional investors own 64.57% of the company’s stock.
WBA stock opened at $82.39 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.82 and a quick ratio of 0.38. Walgreens Boots Alliance Inc has a one year low of $59.07 and a one year high of $83.00. The firm has a market cap of $77.75 billion, a price-to-earnings ratio of 13.61, a P/E/G ratio of 1.30 and a beta of 0.74.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, topping the Zacks’ consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. The firm had revenue of $33.44 billion during the quarter, compared to analysts’ expectations of $33.64 billion. As a group, sell-side analysts anticipate that Walgreens Boots Alliance Inc will post 6.54 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 12th. Shareholders of record on Monday, November 12th will be given a dividend of $0.44 per share. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.76 dividend on an annualized basis and a yield of 2.14%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 29.24%.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction on Thursday, November 1st. The shares were sold at an average price of $79.48, for a total transaction of $217,457.28. Following the completion of the transaction, the director now directly owns 8,207 shares of the company’s stock, valued at $652,292.36. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Kimberly R. Scardino sold 11,970 shares of Walgreens Boots Alliance stock in a transaction on Thursday, November 1st. The stock was sold at an average price of $79.79, for a total transaction of $955,086.30. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 66,706 shares of company stock valued at $5,268,584. Company insiders own 14.80% of the company’s stock.
Several equities analysts recently weighed in on the stock. Pivotal Research raised their target price on shares of Walgreens Boots Alliance from $60.00 to $72.00 and gave the company a “hold” rating in a research note on Monday, October 15th. TheStreet raised shares of Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research note on Wednesday, September 12th. Cowen cut shares of Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating and set a $104.00 target price for the company. in a research note on Monday, July 23rd. BidaskClub raised shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, August 21st. Finally, Loop Capital raised their target price on shares of Walgreens Boots Alliance from $80.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, October 12th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company. Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus price target of $78.22.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
See Also: Dividend Aristocrat Index
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.